Amyotrophic Lateral Sclerosis(ALS)

  1. Home
  2. Speech Therapy For Adult
  3. Amyotrophic Lateral Sclerosis(ALS)

Definition

Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig's disease, is a progressive neurodegenerative disorder affecting motor neurons in the brain and spinal cord, which control voluntary muscle movements. As motor neurons degenerate and die, communication between the brain and muscles ceases, leading to muscle weakness, atrophy, and loss of voluntary movement. ALS eventually impacts essential functions like speaking, swallowing, and breathing.

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.

01

Causes

The exact cause of ALS (Amyotrophic Lateral Sclerosis) is unknown, but it’s believed to result from a combination of genetic and environmental factors, with some cases being linked to specific gene mutations.

1. Genetic Factors:

Familial ALS: About 5-10% of ALS cases are familial, meaning they are inherited, and are linked to mutations in specific genes.

Common Genes: Mutations in genes like C9orf72, SOD1, TARDBP, and FUS are known to cause familial ALS.

Sporadic ALS: While most cases of ALS (about 90-95%) are sporadic, meaning they don’t have a clear family history, some studies suggest that genetic factors may play a role in these cases as well.

Epigenetics: In addition to genetic mutations, epigenetic mechanisms (changes in gene expression without altering the DNA sequence) are also thought to be involved in ALS.

2. Environmental Factors:

Exposure to Toxins: Some studies suggest that exposure to certain environmental toxins, heavy metals (lead, mercury), pesticides, or other chemicals may increase the risk of ALS.

Military Service: Certain studies have found that military veterans, especially those deployed during the Gulf War, may have an increased risk of developing ALS.

Smoking: Smoking is considered a possible environmental risk factor for ALS, with studies suggesting that smokers have a higher risk of developing the disease.

Trauma: Some studies suggest that trauma, including head injuries, may increase the risk of ALS.

02

Symptoms

Early Symptoms:

  • Muscle weakness in limbs, clumsiness, or difficulty holding items.
  • Slurred speech or trouble swallowing (bulbar symptoms).
  • Muscle twitching (fasciculations) and cramps.

Progressive Symptoms:

  • Worsening muscle weakness leading to difficulty walking, using arms, or maintaining posture.
  • Spasticity (tight muscles), poor coordination, and muscle atrophy.
  • Emotional lability (uncontrollable laughing or crying).

Advanced Symptoms:

  • Paralysis of most voluntary muscles.
  • Severe difficulty with breathing and swallowing.
  • Cognitive changes in some cases, leading to frontotemporal dementia.

Observable traits include

 visible muscle wasting, slurred speech, changes in voice quality (thick or nasal), trouble holding the head upright, and pseudobulbar affect (inappropriate emotional responses).

03

Risk Factors

Causes

Genetic predisposition in familial ALS.

Environmental exposures such as toxins or smoking.

Military service has been associated with higher risk.

Age Group Affected

ALS typically affects adults between ages 40–70 but can occur at any age. Risk increases with age up to 75.

Common Scenarios

Early onset may manifest as muscle weakness in one limb or slurred speech.

Progression leads to widespread disability affecting mobility, speech, swallowing,

04

Assessment

Speech-sy’s assessment for Amyotrophic Lateral Sclerosis (ALS) focuses on identifying and managing speech and swallowing difficulties, which are common bulbar symptoms, and may include a patient self-report, oral motor exam, and speech samples to assess dysarthria and dysphagia. 

  • Patient Self-Report:

A patient self-report questionnaire helps to understand the impact of speech and swallowing difficulties on daily activities. 

  • Oral Motor Examination (OME):

This assesses the strength, range of motion, and coordination of the muscles used for speech and swallowing. 

  • Speech Sample Analysis:

  1. Spontaneous Speech: Assessing conversational speech to evaluate dysarthria severity and speaking rate. 
  2. Reading Passage: Evaluating speech intelligibility and identifying areas of weakness in the speech subsystems (respiratory, phonatory, articulatory, and resonatory). 
  3. Diadochokinetic Syllable Rate: Testing the ability to rapidly produce repetitive speech sounds. 
  4. Maximum Phonation Time: Assessing pitch, volume, and endurance. 
  • Swallowing Assessment Procedures

Given that dysphagia is common in ALS, SLPs conduct thorough swallowing assessments:

Clinical Swallow Evaluation:   Observing the patient during eating or drinking to assess swallowing safety and efficiency. This includes noting any signs of aspiration or difficulty.

  • Videofluoroscopic Swallow Study (VFSS):An instrumental assessment where real-time X-ray imaging is used to visualize swallowing mechanics while the patient consumes various food textures.
  • Fiberoptic Endoscopic Evaluation of Swallowing (FEES):A procedure involving an endoscope inserted through the nose to visualize the throat during swallowing without radiation exposure.
  • Patient-Reported Outcomes:Utilizing questionnaires such as the Eating Assessment Tool (EAT-10) to gather information about the patient’s perception of their swallowing difficulties.
  •  Cognitive Communication AssessmentSince cognitive changes can occur in some individuals with ALS, assessing cognitive-communication skills may also be necessary:
  • Cognitive Screening Tools:Instruments like the ALS Cognitive Behavioral Screen (ALS-CBS) or Edinburgh Cognitive and Behavioural ALS Screen (ECAS) help evaluate cognitive functions that may impact communication abilities.

05

Management

Speech-sy’s focus in management of conditions such as swallowing difficulties and communication difficulties such as 

  • Dysphagia intervention

  1. Swallow strategies.
  2. Food modification.
  3. Liquid modification.
  4. Energy conservation.
  5. High-calorie choices.
  6. The importance of oral care for reducing aspiration pneumonia risk.
  7. If symptoms are mild, ask if the patient is interested in an EMST program.
  • Communication intervention

Augmentative and Alternative Communication (AAC):Introducing AAC systems early in the disease progression helps maintain communication abilities as verbal skills decline. Options include:

  1. Low-Tech AAC: Communication boards or picture symbols.
  2. High-Tech AAC: Speech-generating devices that allow users to type messages or select pre-programmed phrases.

Techniques aimed at improving speech intelligibility include:

  1. Slowing down speech rate.
  2. Emphasizing key words.
  3. Practicing clear articulation through targeted exercises
    • Voice Banking:

Encouraging patients to record their voice early in the disease process for use with AAC devices later on, preserving their unique voice for future communication.

06

Outcomes

  • Improved Communication Abilities: Enhanced speech intelligibility and verbal expression during early stages.
  • Effective Use of AAC: Prolonged ability to communicate using speech-generating devices or communication boards.
  • Increased Safety During Swallowing: Reduced aspiration risks through safe swallowing techniques and dietary modifications.
  • Participation in Social Interactions: Maintained social connections and engagement with family, friends, and caregivers.
  • Strengthened Caregiver Support: Caregivers equipped with strategies to facilitate communication and manage feeding challenges.
  • Quality of Life Maintenance: Retained independence in expressing needs and preferences, preserving dignity and autonomy.
  • Psychological Benefits: Reduced frustration, isolation, and depression due to improved communication tools and strategies.

Frequently asked questions

ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative condition that affects nerve cells (motor neurons) in the brain and spinal cord. These neurons control voluntary muscle movement, and as they deteriorate, patients experience muscle weakness, loss of movement, and eventually, difficulties in speaking, swallowing, and breathing.

The exact cause of ALS is unknown. However, both genetic and environmental factors play a role. About 5–10% of cases are inherited (familial ALS), while the majority are sporadic. Risk factors include genetic mutations, exposure to toxins, smoking, military service, and age (commonly 40–70 years).

Early symptoms may include muscle weakness in the arms or legs, slurred speech, muscle cramps, and twitching. As the disease progresses, individuals may face difficulty in walking, speaking clearly, swallowing, or breathing, along with visible muscle wasting.

ALS often leads to bulbar symptoms, which affect speech and swallowing. Assessment includes oral motor exams, speech sample analysis, and swallowing evaluations like VFSS and FEES. These help Speech-Language Pathologists (SLPs) tailor intervention strategies for improved communication and safe swallowing.

While there is no cure, management includes:

  • Swallowing therapy, food/liquid modifications, and safe swallowing strategies.

  • Communication support with AAC (Augmentative and Alternative Communication) devices and voice banking.

  • Cognitive-communication assessments for patients showing signs of cognitive decline.
    These approaches help maintain quality of life, independence, and social interaction.